News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
743,332 Results
Type
Article (43542)
Company Profile (297)
Press Release (699478)
Multimedia
Podcasts (107)
Webinars (20)
Section
Business (207167)
Career Advice (2048)
Deals (35888)
Drug Delivery (138)
Drug Development (82601)
Employer Resources (173)
FDA (16755)
Job Trends (15124)
News (350976)
Policy (33368)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2667)
Accelerated approval (54)
ADA (44)
Adcomms (28)
Allergies (188)
Alliances (50540)
ALS (224)
Alzheimer's disease (1844)
Antibody-drug conjugate (ADC) (512)
Approvals (17158)
Artificial intelligence (727)
ASCO (329)
Autoimmune disease (335)
Automation (60)
Bankruptcy (366)
Best Places to Work (11705)
BIOSECURE Act (22)
Biosimilars (240)
Biotechnology (192)
Bladder cancer (204)
Brain cancer (76)
Breast cancer (797)
Cancer (6258)
Cardiovascular disease (497)
Career advice (1742)
Career pathing (44)
CAR-T (355)
CDC (59)
Celiac Disease (3)
Cell therapy (963)
Cervical cancer (53)
Clinical research (72120)
Collaboration (2195)
Company closure (7)
Compensation (1464)
Complete response letters (90)
COVID-19 (2808)
CRISPR (115)
C-suite (1205)
Cystic fibrosis (158)
Data (8519)
Decentralized trials (3)
Denatured (33)
Depression (167)
Dermatology (94)
Diabetes (654)
Diagnostics (7068)
Digital health (63)
Diversity (13)
Diversity, equity & inclusion (45)
Drug discovery (350)
Drug pricing (206)
Drug shortages (31)
Duchenne muscular dystrophy (300)
Earnings (92592)
Editorial (71)
Employer branding (21)
Employer resources (152)
Events (121947)
Executive appointments (1124)
FDA (20681)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (19)
Frontotemporal dementia (35)
Funding (1821)
Gene editing (245)
Generative AI (63)
Gene therapy (760)
GLP-1 (1100)
Government (4890)
Grass and pollen (6)
Guidances (415)
Healthcare (19327)
Hematology (194)
HIV (85)
Huntington's disease (62)
IgA nephropathy (110)
Immunology and inflammation (306)
Immuno-oncology (107)
Indications (204)
Infectious disease (3174)
Inflammatory bowel disease (224)
Inflation Reduction Act (14)
Influenza (139)
Intellectual property (313)
Interviews (321)
IPO (16789)
IRA (51)
Job creations (3711)
Job search strategy (1443)
JPM (59)
Kidney cancer (20)
Labor market (109)
Layoffs (581)
Leadership (42)
Legal (8028)
Liver cancer (105)
Longevity (35)
Lung cancer (830)
Lymphoma (461)
Machine learning (62)
Management (59)
Manufacturing (1137)
MASH (206)
Medical device (14077)
Medtech (14230)
Mergers & acquisitions (20390)
Metabolic disorders (1623)
mRNA (228)
Multiple sclerosis (195)
NASH (17)
Neurodegenerative disease (454)
Neuropsychiatric disorders (107)
Neuroscience (3457)
Neurotech (1)
NextGen: Class of 2026 (6605)
Non-profit (4607)
Now hiring (79)
Obesity (749)
Opinion (299)
Ovarian cancer (238)
Pain (265)
Pancreatic cancer (341)
Parkinson's disease (389)
Partnered (34)
Patents (624)
Patient recruitment (744)
Peanut (68)
People (60454)
Pharmaceutical (63)
Pharmacy benefit managers (33)
Phase 1 (22565)
Phase 2 (31743)
Phase 3 (23603)
Pipeline (9541)
Policy (345)
Postmarket research (2601)
Preclinical (9592)
Press Release (71)
Prostate cancer (331)
Psychedelics (57)
Radiopharmaceuticals (344)
Rare diseases (1159)
Real estate (6115)
Recruiting (70)
Regulatory (26150)
Reports (57)
Research institute (2483)
Resumes & cover letters (355)
Rett syndrome (43)
RNA editing (25)
RSV (90)
Schizophrenia (184)
Series A (303)
Series B (224)
Service/supplier (12)
Sickle cell disease (120)
Special edition (25)
Spinal muscular atrophy (169)
Sponsored (49)
Startups (3716)
State (2)
Stomach cancer (18)
Supply chain (133)
Tariffs (89)
The Weekly (72)
Vaccines (1166)
Venture capital (116)
Weight loss (480)
Women's health (133)
Worklife (20)
Date
Last 7 days (601)
Last 30 days (2636)
Last 365 days (30750)
2026 (15211)
2025 (30578)
2024 (35641)
2023 (40466)
2022 (51663)
2021 (56199)
2020 (54550)
2019 (47050)
2018 (35490)
2017 (32603)
2016 (32029)
2015 (38107)
2014 (31822)
2013 (26821)
2012 (29042)
2011 (29744)
2010 (27769)
Location
Africa (760)
Alabama (93)
Alaska (7)
Arizona (361)
Arkansas (15)
Asia (40768)
Australia (6658)
California (13880)
Canada (3897)
China (1466)
Colorado (592)
Connecticut (608)
Delaware (429)
Europe (88508)
Florida (2068)
Georgia (444)
Hawaii (3)
Idaho (63)
Illinois (1125)
India (97)
Indiana (627)
Iowa (24)
Japan (576)
Kansas (133)
Kentucky (52)
Louisiana (58)
Maine (77)
Maryland (1674)
Massachusetts (9979)
Michigan (372)
Minnesota (766)
Mississippi (7)
Missouri (148)
Montana (35)
Nebraska (29)
Nevada (148)
New Hampshire (84)
New Jersey (3631)
New Mexico (30)
New York (3639)
North Carolina (1896)
North Dakota (11)
Northern California (6988)
Ohio (417)
Oklahoma (25)
Oregon (43)
Pennsylvania (2764)
Puerto Rico (29)
Rhode Island (51)
South America (1133)
South Carolina (86)
South Dakota (2)
Southern California (5498)
Tennessee (221)
Texas (2222)
United States (49141)
Utah (414)
Vermont (1)
Virginia (335)
Washington D.C. (82)
Washington State (1106)
West Virginia (4)
Wisconsin (135)
Wyoming (2)
743,332 Results for "biologics inc nc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Manufacturing
AbbVie commits $1.4B to NC plant in its largest-ever single campus investment
The Durham plant will manufacture immunology, neuroscience and oncology drugs once AbbVie finishes construction in 2028.
April 23, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Alcami to Expand Laboratory Services Footprint at Durham, NC Facility to Meet Growing Demand in Biologics
October 22, 2025
·
2 min read
Manufacturing
Roche Raises NC Manufacturing Investment to $2B To Support Obesity Challenge
Genentech, a member of the Roche Group, plans to open the facility in 2029 to ramp up capacity to make obesity candidates, including the dual GLP-1/GIP receptor agonist CT-388.
January 21, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Cellution Biologics Inc. Announces Official Entry into the Ocular Market at ASCRS with the Launch of OptiCover™
April 7, 2026
·
3 min read
Press Releases
HCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules
May 21, 2026
·
4 min read
Press Releases
NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2025 Financial Results and Provides Corporate Update
April 16, 2026
·
13 min read
Press Releases
Partner Therapeutics announces submission of supplemental Biologics License Application (sBLA) to FDA for BIZENGRI® (zenocutuzumab-zbco) in NRG1 Fusion Positive Cholangiocarcinoma and Inclusion in updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
April 15, 2026
·
9 min read
Press Releases
WuXi Biologics Included in 2026 Dow Jones Best‑in‑Class World Index and Emerging Markets Index
May 13, 2026
·
3 min read
Press Releases
TempraMed Signs Agreement for Exclusive Distribution Partnership in Brazil, One of the Largest Diabetes and Biologics Markets Globally
Expands Latin America presence with strategic partnership with Mobil Saúde and builds on TempraMed’s recently granted Brazilian patent portfolio Highlights: TempraMed signs Agreement for exclusive distribution in Brazil with Mobil Saúde Comercial Ltda Brazil represents one of the world’s largest markets for diabetes, GLP-1 therapies, and temperature-sensitive biologics1. Diabetes market alone reached USD $2.15 Billion in 2025 Partnership builds on TempraMed’s recently granted Brazilian patent protecting the VIVI Box™ platform Expands TempraMed’s commercialization footprint across Latin America following recent regional expansion initiatives
June 4, 2026
·
10 min read
Press Releases
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State
December 29, 2025
·
7 min read
1 of 74,334
Next
